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Abstract
Background: Understanding the relationship between malaria infection risk and disease outcomes represents a
fundamental component of morbidity and mortality burden estimations. Contemporary data on severe malaria risks
among populations of different parasite exposures are scarce. Using surveillance data, we compared rates of
paediatric malaria hospitalisation in areas of varying parasite exposure levels.
Methods: Surveillance data at five public hospitals; Jinja, Mubende, Kabale, Tororo, and Apac were assembled
among admissions aged 1month to 14 years between 2017 and 2018. The address of each admission was used to
define a local catchment population where national census data was used to define person-year-exposure to risk.
Within each catchment, historical infection prevalence was assembled from previously published data and current
infection prevalence defined using 33 population-based school surveys among 3400 children. Poisson regression
was used to compute the overall and site-specific incidences with 95% confidence intervals.
Results: Both current and historical Plasmodium falciparum prevalence varied across the five sites. Current
prevalence ranged from < 1% in Kabale to 54% in Apac. Overall, the malaria admission incidence rate (IR) was 7.3
per 1000 person years among children aged 1month to 14 years of age (95% CI: 7.0, 7.7). The lowest rate was
described at Kabale (IR = 0.3; 95 CI: 0.1, 0.6) and highest at Apac (IR = 20.3; 95 CI: 18.9, 21.8). There was a correlation
between IR across the five sites and the current parasite prevalence in school children, though findings were not
statistically significant. Across all sites, except Kabale, malaria admissions were concentrated among young children,
74% were under 5 years. The median age of malaria admissions at Kabale hospital was 40 months (IQR 20, 72), and
at Apac hospital was 36 months (IQR 18, 69). Overall, severe anaemia (7.6%) was the most common presentation
and unconsciousness (1.8%) the least common.
Conclusion: Malaria hospitalisation rates remain high in Uganda particularly among young children. The incidence
of hospitalized malaria in different locations in Uganda appears to be influenced by past parasite exposure, immune
acquisition, and current risks of infection. Interruption of transmission through vector control could influence age-
specific severe malaria risk.
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Background
Despite reductions in the risk of malaria infection,
morbidity and mortality across sub-Saharan Africa
(SSA) over the last two decades, gains have not been
uniform in the region [1, 2]. Six countries account for
nearly half of the world’s malaria disease burden in-
cluding Nigeria (25%), Democratic Republic of the
Congo (12%), Uganda (5%), and Cote d’Ivoire,
Mozambique and Niger (4% each) [2]. The latest fig-
ures for Africa suggest that life-threatening morbidity
leading to death from malaria across Africa remains
unacceptably high [2].
During the 1990s and early 2000s the relationship
between the frequency of malaria parasite exposure
and severe disease incidence was the subject of in-
tense investigation across different transmission set-
tings in African [3–12]. These studies formed the
basis of provisional modelling of the relationship be-
tween infection exposure and severe disease outcomes
[13–16]. The likelihood of a new malaria infection
resulting in life-threatening disease is principally
determined by the ability of the host to mount an im-
mune response; a function of previous parasite expos-
ure, age and prompt treatment of mild disease with
effective medicines. The relationship between parasite
exposure and disease outcome represents the funda-
mental basis of the determination of the malaria
disease burden in time and place [17–19]. Over the
last 15 years there have been few investigations on the
clinical epidemiology of severe malaria, notably during
a time of changing parasite transmission intensity and
treatment access across SSA, with research into severe
malaria becoming a neglected topic [20].
In Uganda, despite a reduction in national under-
five malaria prevalence from 30.4% in 2016 [21] to
16.9% in 2018–2019 [22], modelled projections, show
that the country experienced approximately 12.3
million malaria cases and 13,203 malaria deaths in
2018, with little evidence of change since 2016 [2].
Malaria continues to contribute to 20–30% of all
paediatric admissions to hospitals across the country
[23], overwhelming emergency clinical services. The
last comparisons of the rates and clinical phenotypes
of hospitalized malaria, at three sites in Uganda, was
undertaken in 2002–2003 [7]. Almost 20 years on, the
link between a history of infection and severe disease
is poorly defined, limiting our ability to understand
the effects of infection prevention through vector
control on disease profile in Uganda. Here we present
a comparison of the rates of malaria hospitalisation
and the clinical spectrum of severe disease across five
catchment areas close to district hospitals where the
historical and current malaria parasite exposure has
been characterized.
Methods
Hospital surveillance
In 2010, the Uganda Malaria Surveillance Project
(UMSP), in collaboration with the National Malaria
Control Programme (NMCP), established an inpatient
malaria surveillance program in the children’s wards at
six public hospitals [24–27]. These six hospitals reflected
the diversity of malaria transmission across Uganda. A
structured Medical Record Form (MRF) was developed,
enabling a standardized information record system for
all admissions at participating sites. The MRF facilitated
capture of detailed individual level information including
patient demographics, residential address, presenting
symptoms and clinical signs, laboratory test results,
treatment prescribed, diagnosis and outcome upon dis-
charge. Attending nurses, clinical officers, and physicians
completed the MRF. UMSP supplied MRFs and basic
malaria laboratory supplies. Health workers were trained
on the use of the MRF, importance of good medical
record keeping, use of data to improve the quality of
services, and proper case management of uncomplicated
and severe malaria. Emphasis was placed on ensuring all
children were screened for malaria parasites using mi-
croscopy and/or malaria Rapid Diagnostic Tests (mRDT)
on admission or during admission. Haemoglobin
concentrations were only performed when requested by
clinicians.
In 2016, the inpatient malaria surveillance program
was expanded to provide a platform for investigation of
aetiologies of Acute Febrile Illnesses (AFI) [27].
Improvements were made to the coverage of routine
malaria testing and the documentation of patient’s
physical address. The MRF was adapted to incorporate
additional variables relevant to expanded bacterial and
viral diagnostic capacity, described elsewhere [27]. Under
the AFI program, the data management system was
upgraded to a web-based data management system
hosted on the District Health Information System
(DHIS-2), allowing for real time data entry.
The present study focused on a retrospective analysis
of admissions to five hospitals from 2017 to 2018 among
children aged 1 month to 14 years from communities
located close to five hospitals shown in Fig. 1 and
Table 1. Arua hospital was not included in this analysis
because it served a large refugee community hence
might not have represented a stable population subject
to local malaria exposure.
Case definitions
Patient diagnoses were made at admission and at
discharge. A check list of most common diagnoses was
incorporated in the MRF. Upon evaluation of patients,
based on their judgment informed by history, examin-
ation findings and available test results, clinicians
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checked one or more diagnosis. It was not unusual for
children to have more than one diagnosis; occasionally
complications of illness were listed as diagnoses. A free
text field was included for recording diagnosis not in-
cluded in the list of available diagnosis. Patients who had
any record under the possible diagnoses, or notes, of
AIDS, TB, Sickle Cell Disease, epilepsy, congenital mal-
formations, poisoning, burns, trauma, snake or animal
bites, elective surgery or measles were immediately
excluded from the data series, irrespective of whether
they had a diagnosis of malaria. Here we presumed the
underlying conditions to be the primary cause for admis-
sion and malaria a coincidental diagnosis. Patients who
had any record of malaria were then identified and
checked against malaria test (microscopy or mRDT) re-
sults, those who had a negative malaria test results were
reclassified as unknown or replaced by other diagnoses if
reported.
Malaria admissions were further classified according
to the criteria of severe malaria approximating to those
defined by the WHO [30] including, cerebral malaria,
severe malaria anaemia, respiratory distress and haemo-
globinuria, based on admission symptoms, signs, and la-
boratory findings. Consciousness was defined through
observation of the child at admission. Unconsciousness
was not formally evaluated using a Blantyre or Glasgow
coma score, rather an APVU (Alert, responds to Pain or
Voice or Unconscious) score was used [31], where U,
approximates to a Blantyre Coma Score of 3 or less.
Given the incomplete nature of haemoglobin results on
all malaria admissions, it was not possible to use the
strict definition of severe malaria anaemia (SMA) [30].
Therefore, SMA was classified if a) available haemoglo-
bin results at, or during, admission was< 5 g/dl; b) for
those without a haemoglobin result < 5.0 g/dl, if the
child received blood transfusion during admission; and
then c) if not classified by a) and b) whether they pre-
sented on admission with clinical signs of severe pallor.
Respiratory distress was classified as deep breathing
recorded through observation at admission. Haemo-
globinuria was classified as present based on a reported
history of passing ‘tea’ coloured urine by caretakers of
Fig. 1 Location of five sentinel districts (grey) and parish catchment areas used to define malaria hospitalisation rates (orange) at select hospitals
(blue dots)
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the admitted child. Other features of severe malaria [30]
could not be classified from information available on the
MRFs, including prostration (age relevant inability to sit,
stand or breastfeed not standardized between sites),
hyper-parasitaemia (parasite counts per microlitre not
recorded) or multiple convulsions within 24 h. Whether
a child had had a seizure during the illness episode was
documented, however, the number, type and duration of
seizures was not recorded. The outcome of admission
was incomplete across all hospitals, including large num-
bers having absconded prior to formal discharge, making
case-fatality rates impossible to compute overall or for
Table 1 Hospital and catchment characteristics
Characteristics Apac District
Hospital
Tororo District
Hospital
Mubende Regional
Referral Hospital
Jinja Regional
Referral Hospital
Kabale Regional
Referral Hospital
Surveillance period (months)a Apr 2017-Dec
2018 (21 months)
Apr 2017-Dec
2018 (21 months)
Jan 2017-Dec 2018
(24 months)
Jan 2017-Dec
2018 (24 months)
Mar 2017-Dec
2018 (22 months)
District, Region Apac, Lango Tororo, Bukedi Mubende, North
Buganda
Jinja, Busoga Kabale, Kigezi
Altitude, meters above sea level 1054 1220 1314 1182 1862
Average annual rainfall during surveillance period
(mm/year)
1587 1474 1062 1445 1050
HbAS frequency [28] 19.2 19.6% 10.9% 19·5% 2.6%
District parasite prevalence 2010–2016, (number
of surveys [number individuals examined]b
42.0% (26) [917] 56.3% (105)
[38078]
22.9% (2) [48] 41.4% (45) [3112] 4.9% (3) [122]
History (dates) of LLIN mass distribution [23] May 2014, Feb
2017
May 2017 Nov 2017 Mar 2017 May 2014, Jun
2017
History (dates) of IRS campaign [23] Mar 2008 DDT
Feb 2010 Alpha-
cypermethrin
Aug 2010
Bendiocarb
Jan, May, Nov
2011 Bendiocarb
Apr, Oct 2012
Bendiocarb
Apr, Nov 2013
Bendiocarb
Apr 2014
Bendiocarb
May 2017 Actellic
Dec 2014
Bendiocarb
Jun, Nov 2015
Bendiocarb
Jun 2016 Actellic
Jul 2017 Actellic
Jun 2018 Actellic
None None Dec 2006
lambda-
cyhalothrin
Mar 2007
lambda-
cyhalothrin
Total admissions during surveillance period 4931 7122 4410 13,320 2314
Total malaria admissions during surveillance
period
2815 1840 1870 3692 28
Catchment Parishes Atik, Amii
Abedi, Atopi
Osia, Osukuru
Nyakesi,
Nyangole
Kabowa, Katente
Kibalinga
Buwende,
Kimaka,
Mafubira,
Masese,
Walukuba
East&West
Bugarama,
Kahoro
Kigata, Muyumbu,
Nyakagyera
Minimum-maximum distance to hospital (km) 2.3–16.3 2.0–11.5 3.4–18.6 1.3–9.0 3.9–11.7
Census projected population years at risk 2017–18
aged 1month to < 15 years
37,680 40,852 48,701 82,671 22,504
School survey results within selected parishes
Number of schools/number of pupils 6–16
years
6/601 7/824 4/403 8/800 7/800
P. falciparum parasite prevalence (microscopy) 58.2% 7.5% 32.2% 10.2% 0.1%
Use of LLIN night before survey 23.7% 41.6% 43.5% 54.3% 89.2%
IRS reported in child’s household in last 12
months
6.6% 97.4% 1.2% 5.5% 0.7%
aSurveillance for AFI began at different times at each of the five hospitals
bSurvey data from district assembled and described in ref [1], available at [29] and updated with additional data (see Methods), used here in covering 2010–2016
to represent parasite exposure in the district prior to the surveillance period. School survey data represent a more location-specific estimate of infection
prevalence at the end of the hospital surveillance period (2019)
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specific disease phenotypes. All relevant data were
abstracted from the electronic MRF databases. All the
subsequently selected patients aged 1month to 14 years
from the catchment areas with missing data in the elec-
tronic database were crosschecked against original hard
copy clinical and laboratory registers for completeness.
A set of unique identifiers were used to match electronic
records to entries in the register.
Defining residences and denominators
A variety of information on each patient’s residential ad-
dress was available on the MRF. This information was
used to locate residential parishes (third level census ad-
ministration areas). Lists of village names per parish,
Google Earth and other digital place name gazetteers
[32] were used to provide a parish code for all the mal-
aria admissions. Rural, or peri-urban, parishes were then
selected that were closest, within 20 km, to the hospital.
Urban residences were excluded, as anecdotal evidence
suggests that they may have been provided by visitors
from other areas rather than local residents. Twenty
kilometers is within the distances used to define opti-
mized hospital catchments in Tanzania [33], Uganda
[34, 35] and Kenya [36–38], accounting for most acute
febrile admissions. Furthermore, the selection of parishes
close to the sentinel hospital excluded communities that
may have had better access to “competing” hospitals
elsewhere in respective regions.
The selected parishes were then used to extract total
population counts from the 2014 national census [39],
projected to 2018 using reported district intercensal
growth rates. Total population counts were corrected to
single year age group (0-, 1-, 2- … 14 years) denomina-
tors using regional rural, household census data from
the 2016 Demographic and Health Survey in each re-
spective region [40]. Age-specific populations at risk
were finally corrected to the number of person-years-of
observation depending on the surveillance period, with
the first year of life adjusted for 11 months.
Defining transmission intensity
To understand the role of parasite exposure on the epi-
demiology of severe malaria risks both historical and
current infection prevalence were defined. It was not
possible to identify specific survey data on community-
based malaria prevalence for each of the catchment areas
selected for the present study. However, district-wide
survey data undertaken between 2010 and 2016 among
children aged less than 15 years, where at least 15
children had been examined with microscopy were iden-
tified from previous datasets [1, 29] updated with other
sub-national survey data [41]. Data were aggregated as
mean estimates of age-corrected (2–10 years) prevalence
and crude estimates of prevalence (total positives/total
examined) for all surveys 2010–2016 pre-hospital
surveillance period.
To represent contemporary infection prevalence,
school-based surveys within the catchment parishes se-
lected for the 2017–2018 surveillance period were
undertaken at the end of the hospital recruitment period
in 2019. School children provide a simple, reliable source
of community-level malaria prevalence [42, 43]. Catch-
ment parishes were used to define sample size. An esti-
mate of expected district prevalence was used from
previously analysed malaria prevalence risk undertaken
by the NMCP [44]. A precision for the estimate was set
at 5% and the confidence interval set at 95%, and assum-
ing a non-response rate of 10%. Based on these assump-
tions, a total of 3400 children in 33 schools participated
in the survey. For each area, schools were randomly se-
lected from district inventories of public, day schools,
100 to 150 children were randomly selected to partici-
pate from classes Primary One to Primary Six from each
school in the region. Children of consenting parents
were interviewed to collect information on demograph-
ics, mosquito net usage during the night prior to the
survey, use of indoor residual house-spraying in their
homesteads and recent history of illness including fever.
A finger prick blood sample was collected for thick and
thin blood smear and a malaria rapid diagnostic test
(mRDT) (CareStart™) for detection of malaria parasites.
Thick and thin blood smears were stained with 2%
Giemsa for 30 min. 100 high power fields were used to
detect and quantify infection using experienced UMSP
microscopists. mRDT results were read as per manufac-
turer’s instructions. Children with positive mRDT results
were treated with artemether-lumefantrine as per
recommended national guidelines [45]. Slide results were
considered final if the first and second expert readings
agreed on parasites densities (< 25% level of disagree-
ment). If the first and second expert readings were
discordant, a third expert-reader was used to arbitrate.
Analysis
All clinical data were stored on the DHIS-2 platform
and school data were double entered using EpiData
(v3.1). Data analysis was performed in STATA (version
14; STATA Corp., College Station, TX, USA) and R
version 3.6.1 (R Core Team (2019), Vienna, Austria).
Patient’s demographics were summarised as proportions
and median ages with interquartile range (IQR). Kruskal
Wallis was used to test for differences in median age.
The incidence rate (IR) of hospitalised malaria was de-
fined as the number of cases with a primary diagnosis of
malaria (confirmed by microscopy or mRDT) divided by
person-years of observation expressed per 1000 people.
Since re-admissions were not documented all malaria
admissions were included in the IR calculation, and
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therefore strictly best referred to as period prevalence.
The prevalence of each severe malaria phenotype was
defined as the number of hospitalised children with a
specified severe malaria phenotype divided by the
number of all hospitalised children without missing in-
formation required to classify by that phenotype. The
age specific, site specific, and syndrome specific IR with
95% confidence intervals were computed using the exact
Poisson distribution. Poisson regression was used to
compute the incidence rate ratios (IRR) for the age
groups < 1 year, 1–4 years, 5–9 years and 10–14 years,
adjusted for site. The association between parasite preva-
lence and IR of malaria hospitalisation was determined
using a Spearman rank correlation coefficient (rho) and
confidence intervals constructed using Fisher’s z
transformation.
Results
Characteristics of study sites
The five rural, catchment parishes used to define
hospital admission rates are shown in Table 1 and Fig. 1.
Surveillance at each of the five hospitals started at differ-
ent times in 2017 and observation periods ranged be-
tween 21 and 24months, ending in December 2018
(Table 1). The projected population years of observation
for children aged 1 month to less than 15 years within
each catchment area is shown in Table 1. Catchment
areas were between 2 and 19 km from respective
hospitals.
The five selected hospital sites (Fig. 1) and the districts
where they are located, represent historically stable,
endemic malaria ecologies as demonstrated by the high
frequencies of the heterozygote state of the sickle cell
gene (haemoglobin AS) and high average annual rainfall.
The exception being the high-altitude district of Kabale;
a low transmission setting (Table 1). Between 2010 and
2016, prior to the hospital surveillance, community-
based childhood parasite prevalence in the five districts
ranged from 4.9% in Kabale to 56.3% in Tororo. During
this period the natural endemicity in Apac was altered
using biannual rounds of indoor residual spraying (IRS)
with Bendiocarb from 2010 to 2014 [46] (Table 1). IRS
was suspended in Apac in May 2014 [47], however one
round of IRS with Actellic® was conducted in May 2017
[48]. In Tororo, biannual IRS with Bendiocarb began in
December 2014 through 2015, in 2016 IRS involved an-
nual spray rounds with Actellic® [49] and continued
throughout the hospital surveillance period 2017–2018
(Table 1). Vector control in Mubende, Kabale and Jinja
has relied only on Long-Lasting Insecticide treated Net
(LLIN) distribution.
The school-based surveys among children aged 6–16
years, undertaken at the end of the hospital surveillance
period, demonstrated a diverse pattern of malaria
endemicity ranging from < 1% Plasmodium falciparum
slide positivity in Kabale to 54% in Apac (Table 1).
These estimates of community-based infection preva-
lence reflect historical transmission ecology (Kabale) and
recent suspension (Apac) or introduction (Tororo) of
IRS. Furthermore, reported LLIN use the night prior to
the survey by school children was lowest in Apac (24%),
and between 40 and 90% in all other catchment areas
(Table 1).
Age and malaria admissions from selected parishes
One thousand seven hundred eight admissions aged 1
month to 14 years of age with a primary diagnosis of
malaria, confirmed by microscopy and/or mRDT, with-
out underlying causes for admission were identified with
a residence within selected catchment areas across the
five hospitals. The overall hospitalisation incidence rate
(IR) across the combined sites was 7.3 (95% CI 7.0, 7.7)
per 1000 children 1 month to 14 years per annum. The
annualized rates of malaria hospitalisation varied signifi-
cantly between hospital catchments, with the lowest
rates observed at the very low transmission site at
Kabale (IR = 0.3; 95% CI: 0.1, 0.6) and the highest at
Apac (IR = 20.3; 95% CI: 18.9, 21.8) (Table 2).
Among all admissions the median age of malaria hos-
pitalisation was 30 months (IQR: 17.5, 60), 1257 (73.6%)
of all admissions were aged less than 5 years. Children
presenting to Kabale hospital had the highest median
age (40 months; IQR: 20,72), followed by Apac (36
months; IQR: 18, 69) and the remaining sites the median
age of the malaria admissions was between 27 and 30
months (Table 2). Except for Kabale, rates of admission
at each of the other four sites increased after the first
birthday, peaking during the second year of life, and
declining thereafter (Fig. 2). Rates of malaria hospitalisa-
tion were lower among children aged 5–9 years (IRR =
0.28; 95% CI: 0.25, 0.32; p < 0.001) and among those
aged 10–14 years (IRR = 0.09; 95% CI: 0.07, 0.11) as
compared to children aged 1–4 years after adjusting for
site (Supplement S1).
There was correlation between current catchment-
specific school-based infection parasite prevalence and
the overall malaria admission incidence rate in each site
(rho = 0.70; 95% CI: − 0.48, 0.98) (Fig. 3), although this
did not reach statistical significance (p = 0.19). The
association remained unchanged even when we re-
stricted the rates of admission to children aged 1–23
months of age (rho = 0.70; 95% CI: − 0.48, 0.98; p = 0.19),
a period most likely representative of current transmis-
sion intensity (Supplement S2).
Prevalence of severe malaria phenotypes
Overall, unconsciousness (a surrogate marker of cerebral
malaria, 30/1674; 1.8%) was the least common severe
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disease phenotype among all admissions. However, un-
consciousness was present in 1/6 of the admissions at
Kabale and was more common in Mubende (19/253;
7.5%) compared to other sites (Table 3). The composite
definition of severe malaria anaemia (SMA) depended
on the availability of information, a total of 129 (7.5%)
SMA events were recorded, 37 based on haemoglobin,
63 based on a history of blood transfusion and 29 based
on a presentation of severe pallor. Of all admissions, 34
(2%) and 10 (0.6%) patients could not be classified for
unconsciousness and SMA, respectively, for lack of rele-
vant information. Overall, the composite indicator of
SMA (129/1690; 7.6%) was considerably more common
than unconsciousness and most prevalent among mal-
aria admissions at Mubende (51/253; 20.2%) and least
prevalent in Apac (15/762; 2.0%) (Table 3). No children
with SMA were noted in Kabale hospital. Evidence of re-
spiratory distress was present among 55/169 (3.2%) mal-
aria admissions, a history of passing ‘tea’ coloured urine
(haemoglobinuria) was reported as present in 84/1691
(5%), and highest at Mubende 21/253 (8.3%) (Table 3).
Overall, children who were unconscious (median age 60
months, IQR: 26, 84) were older than those who had se-
vere anaemia (median age 36 months, IQR: 18, 72),
respiratory distress (median age 19 months, IQR: 13, 42),
and haematuria (median age 48months, IQR: 23, 72),
(p < 0.001) (Table 3).
Discussion
We have presented an ecological comparison of the rates
of malaria hospitalisation against estimates of historical
and current levels of malaria transmission from five
communities in Uganda. Unsurprisingly, in areas of
historical and contemporary very low transmission,
paediatric malaria hospitalisation is uncommon (Kabale).
Consistent with earlier observations in high transmission
settings in Africa during the 1990s-early 2000s [3–12],
Apac exhibited an extremely high incidence of hospital-
ized malaria among children aged under 24 months of
age (Fig. 2). However, unlike previous reported age-
prevalence and incidence estimates from areas with
hyper-endemic transmission studied in the 1990s [3–12],
Apac demonstrated an age-profile of hospitalized
malaria incidence that included a much higher incidence
among older children aged 5–10 years and 10–15 years
(Table 2; Fig. 2). The unexpectedly high rate of malaria
admissions among older (> 5 years) children in Apac,
traditionally an area of intense transmission, may have
Table 2 Measures of malaria morbidity in different age groups among children hospitalized with malaria at five public hospitals in
Uganda
Apac District
Hospital
Tororo District
Hospital
Mubende Regional
Referral Hospital
Jinja Regional
Referral Hospital
Kabale Regional
Referral Hospital
Overall (1 month - 14 years)
Person Years Observation at Risk 37,680 40,852 48,701 82,671 22,504
Median age in months (IQR) 36 (18, 69) 28 (17, 48) 30 (16, 54) 27 (18, 54) 40 (20,72)
Number of cases 764 317 253 368 6
Incidence Rate (95% CI) 20.3 (18.9, 21.8) 7.8 (6.9, 8.7) 5.2 (4.6, 5.9) 4.5 (4.0, 4.9) 0.3 (0.1, 0.6)
< 1 year
Person Years Observation at Risk 1983 2670 3251 5469 1365
Number of cases 92 37 30 54 0
Incidence Rate (95% CI) 46.4 (37.4, 56.9) 13.9 (9.8, 19.1) 9.2 (6.2, 13.2) 9.9 (7.4, 12.9) 0 (0, 2.7)
1–4 years
Person Years Observation at Risk 10,284 12,142 14,922 23,781 6537
Number of cases 436 213 164 228 3
Incidence Rate (95% CI) 42.4 (38.5, 46.6) 17.5 (15.3, 20.1) 11.0 (9.4, 12.8) 9.6 (8.4, 10.9) 0.5 (0.1, 1.3)
5–9 years
Person Years Observation at Risk 13,124 13,685 16,650 28,285 7807
Number of cases 171 58 50 70 3
Incidence Rate (95% CI) 13.0 (11.1, 15.1) 4.2 (3.2, 5.5) 3.0 (2.2, 4.0) 2.5 (1.9, 3.1) 0.4 (0.1, 1.1)
10–14 years
Person Years Observation at Risk 12,289 12,355 13,878 25,136 6793
Number of cases 65 9 9 16 0
Incidence Rate (95% CI) 5.3 (4.1, 6.7) 0.7 (0.3, 1.4) 0.6 (0.3, 1.2) 0.6 (0.4, 1.0) 0 (0, 0.5)
Incidence rate per 1000 children p.a
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resulted from the rapid reduction in malaria parasite ex-
posure following the IRS campaigns in 2010–2014 [46].
The historical reduction in transmission may have facili-
tated the emergence of an ‘atypically’ non-immune co-
hort of older children in 2017–18 unusually susceptible
to malaria and its complications. Periods of sustained
malaria control, followed by relaxation or withdrawal of
effective interventions, has been shown to result in re-
bound [50], which was also documented in Apac [47].
Since 2014, the traditionally high transmission (Table
1) region in Tororo, continues to be under intensive IRS
(Table 1) [49], sustaining protection against infection
among children aged 1 month to 4 years of age at-risk of
hospitalisation with malaria during the 2017–2018
surveillance period. In Tororo children older than 5
years would have been exposed to high transmission in-
tensity from birth (Table 1). Contemporary estimates of
infection prevalence are 7.5% compared to an estimated
historical prevalence above 50% (Table 1). The age pattern
and broad overall rate of malaria hospitalisation were
similar in Tororo compared to Jinja and Mubende, with
current transmission between 10 and 32% respectively,
with 74% of all paediatric admissions occurring before the
5th birthday and a peak in the second year of life (Table 2;
Fig. 2). Despite a significant reduction in parasite exposure
in Tororo, rates of malaria hospitalisation remain high
compared to other sites of sustained high transmission
(Mubende) or in transition without the use of IRS (Jinja).
Fig. 2 Age-specific malaria admission rates per 1000 person-years of observations at five sites (showing 95% confidence intervals)
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Infection risks have not been eliminated in Tororo and
some premunition might still be occurring among young
children. However, cessation of IRS might result in a
changing age-profile of disease as witnessed in Apac.
Overall, cerebral malaria was comparatively uncom-
mon as a severe complication of malaria admissions and
when observed had a higher mean age compared to
other severe disease phenotypes (Table 3). This has been
recently confirmed in Kenya [31]. Severe malaria an-
aemia (SMA), as defined in our series based on available
information on haemoglobin concentrations, transfusion
history or severe pallor at admission, was a more com-
mon presentation, and consistent with earlier observa-
tions in Uganda [7] and recently reported in Kenya [31].
Those with SMA, while younger than patients present-
ing with cerebral malaria, include older children and this
Fig. 3 Malaria admission rates for children aged 1month-14 years per 1000 person-years of observation versus school-based malaria parasite
prevalence at the end of the surveillance period
Table 3 Prevalence of severe malaria phenotypes among resident children in defined catchments areas of specific hospitals
Severe malaria phenotype All sites Apac District
Hospital
Tororo District
Hospital
Mubende Regional
Referral Hospital
Jinja Regional
Referral Hospital
Kabale Regional
Referral Hospital
Unconscious
n/N (%) 30/1674 (1.8%) 4/753 (0.5%) 1/296 (0.3%) 19/253 (7.5%) 5/366 (1.4%) 1/6 (16.7%)
Median age in months (IQR) 60 (26, 84) 90 (45, 132) 18 (18, 18) 48 (24, 84) 70 (26, 96) 60 (60, 60)
Respiratory distress
n/N (%) 55/1699 (3.2%) 14/762 (1.8%) 14/310 (4.5%) 18/253 (7.1%) 9/368 (2.5%) 0/6 (0%)
Median age in months (IQR) 19 (13, 42) 19 (14, 41) 14 (9, 66) 31 (15, 42) 15 (12, 26) –
Tea coloured urine
n/N (%) 84/1691 (5.0%) 43/761 (5.7%) 8/303 (2.6%) 21/253 (8.3%) 12/368 (3.3%) 0/6 (0%)
Median age in months (IQR) 48 (23, 72) 41 (18, 72) 32 (20, 42) 60 (48, 72) 63 (32, 90) –
SMA
n/N (%) 129/1690
(7.6%)
15/762 (2.0%) 21/307 (6.8%) 51/253 (20.2%) 42/368 (11.4%) 0/6 (0%)
Median age in months (IQR) 36 (18, 72) 70 (24, 108) 36 (24, 50) 36 (18, 60) 42 (18, 72) –
SMA Severe malaria anaemia, described in text; the incidence rate is per 1000 children p.a., n The number of hospitalised children with a specified severe malaria
phenotype, N The number of all hospitalised children without missing information required to classify by that phenotype
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severe disease phenotype is not restricted to very young
children, with 37.5% of those defined as SMA being 5–
14 years of age. The observation of higher rates of SMA
among older children requires further investigation and
how to improve case-management in all pediatric age
groups [51, 52]. Haemoglobinuria was reported as the
presence of “tea colored urine” by caretakers among
4.8% of all malaria admissions (Table 3). The reported
haemoglobinuria may be a part of the Blackwater fever
syndrome, an increasingly common feature of severe
malaria in parts of Uganda [53, 54], but interestingly
might be less common outside Uganda [53].
We have described malaria admission among commu-
nities with relatively easy access to emergency care ser-
vices in Uganda. The overall incidence of hospitalisation
with malaria was 7 per 1000 children aged 1 month to
14 years of age per annum, ranging from very low levels
in areas with very little transmission to over 20 per 1000
per annum in high transmission settings. These rates of
hospitalized care for paediatric malaria are high and pro-
vide confirmatory evidence of the continued importance
of malaria as a contributor to poor child survival in
Uganda. Our estimates do not capture those with severe
malaria who seek care elsewhere or die before reaching
hospital. Treatment seeking for severe malaria remains
poorly defined and requires further investigation, not
just for the interpretation of hospitalised disease inci-
dence but to also define points of improved pre-referral
care [55–57]. Our results therefore represent approxi-
mate estimates of community acquired malaria requiring
in-patient care. However, selecting catchments with rela-
tively easy access to emergency care allows for a more
reliable estimate of severe, potentially life-threatening
disease incidence, compared to incidence defined among
communities with limited access. A more comprehensive
understanding of the epidemiology of severe, life-
threatening disease and death requires prospective
surveillance, however there are very few studies that
have examined the long-term parasite exposure versus
changing severe diseases profile in Africa [58].
The electronic AFI surveillance system operated at the
sentinel hospitals introduced a standardized paediatric
admission record system including universal malaria
testing. This system provided opportunities to examine
linked spatial and clinical data. Standardized admission
record systems have been introduced in other settings,
as part of routine health systems improvement tools
[59–61]. Inevitably, the completeness and reliability of
information available within hospital data systems de-
pends upon resources and the intended objectives of
surveillance programs. Hospital surveillance provides
unique opportunities to monitor the changing clinical
epidemiology of severe malaria and other febrile illnesses
and with minimal investment could be implemented in a
sustained form at national sentinel sites [62]. Invest-
ments are required for admission and data clerks, infor-
mation and data systems and ensuring a basic minimum
supply of laboratory supplies. These surveillance systems
of severe disease we contend would be valuable re-
sources to understand the changing landscape of severe
disease epidemiology across Africa.
Conclusion
Our results suggest that the epidemiology of severe, life-
threatening malaria is consistent with early and frequent
parasite exposure, and subsequent acquisition of im-
munity. In high transmission settings, under conditions
of intense malaria control and reduced transmission for
several years, the risk of severe malaria shifts to older
children. This shift manifests in later years, as an in-
crease in risk of severe malaria in older children,
otherwise unexpected if transmission had not been
interrupted. However, despite this increase, severe dis-
ease remains a rare event in children aged 10 years and
above. The present analysis highlights the importance of
both historical and current malaria exposure upon pat-
terns of severe disease in a community. Current disease
risks are determined by present exposure, but in the
context of historical exposure and acquired immunity,
complicating interpretation of observations based on
ecological comparisons between sites over time.
However, linkage of well-defined communities with easy
access to hospital care provides better insight into the
changing disease epidemiology resulting from changing
transmission intensity. Indeed, longer-term hospital
surveillance linked to the geography of hospital access,
malaria control interventions, and parasite exposure of-
fers future possibilities for better understanding of the
epidemiology of severe malaria in Africa.
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